Mary Pat Moyer, PhD
Founder, CEO and Chief Science Officer, INCELL
Dr. Moyer brings over 4 decades of broad-ranging expertise, knowledge, integrity and leadership to INCELL’s regenerative medicine, cell and tissue therapies, and infectious diseases programs, and to the product development and manufacturing of biologics, devices and drugs. Dr. Moyer has a Ph.D. in Microbiology (Univ. Texas at Austin, 1981) and is an elected member of the American Academy for Microbiology. Previously a University of Texas Health Science Center at San Antonio tenured Professor, Surgical Research Division Head, Director of the Center for Human Cell Biotechnology, and appointed faculty member of 5 departments (1981-2001), Moyer is currently an adjunct Professor. She has consulted for many companies and served local, state, national and international entities, including NIH, WHO, FDA, FMDIC, NASA, US State Dept., TWIC, BioMedSA, ICID, and more. Moyer has received many grants, contracts and awards of recognition for leadership as a scientist, entrepreneur, STEM educator and life sciences technology community activist. Her awards include the international Athena Award, EY Entrepreneur of the Year, Texas Healthcare and Biosciences Institute “Top Ten Texas CEOs in Life Sciences”, American Association of University Women (AAUW) “Breaking the Glass Ceiling Award”, and many more.